Latest filing published 19 Aug 2022 for Enovix Corp.
Insider track record
No signal scores available.
Eclipse GP III, LLC: trading record in brief
This profile gathers the share dealings of Eclipse GP III, LLC across 2 companies, led by Lucira Health, Inc. and Enovix Corp. Over a trading history stretching from 9 February 2021 to 18 August 2022, the count stands at 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 19 August 2022: a transaction, in Enovix Corp. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Eclipse GP III, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0000899243-22-029293:1
- 50,000 shares0Common StockSEC:0000899243-22-029293:2
- 5,000,000 shares0Common StockSEC:0000899243-22-029293:0
- 473,729 shares@ US$13.60100.0% of flowCommon StockSEC:0001209191-21-009051:4
- 976,852 sharesCommon StockSEC:0001209191-21-009051:0
- 877,445 sharesCommon StockSEC:0001209191-21-009051:1
- 185,512 sharesCommon StockSEC:0001209191-21-009051:2
- 3,710,257 sharesCommon StockSEC:0001209191-21-009051:3
8 of 8 declarations
